This post has been archived and contains information that may be out of date.
CHA DataSuite has issued a hospital-specific analysis of the value-based purchasing (VBP) program.
The analysis, which is designed in the business intelligence platform, is intended to provide hospitals a preview of the program’s potential impact for federal fiscal year (FFY) 2024 and based on the most recent publicly available data and program rules established by the Centers for Medicare & Medicaid Services (CMS).
CMS is neither penalizing nor rewarding hospitals for the FFY 2022 and FFY 2023 VBP programs due to the impact of the COVID-19 pandemic. Although CMS did provide a subset of data for individual measures and the clinical outcomes (FFYs 2022 and 2023) and efficiency (FFY 2023) domains, it did not provide the total performance score or adjustment factors, so no impacts were calculated.
FFY 2024 VBP performance periods are impacted by the extraordinary circumstances exception granted by CMS in response to the public health emergency, so no claims data or chart-abstracted data reflecting services provided Jan. 1-June 30, 2020, will be used in the calculations for the VBP program.
The FFY 2024 figures are estimates, based on CMS’ fourth quarter 2022 update of Care Compare.
